Molecular and biological factors in the prognosis of head and neck squamous cell cancer
- PMID: 37493876
- DOI: 10.1007/s11033-023-08611-1
Molecular and biological factors in the prognosis of head and neck squamous cell cancer
Abstract
The objective of the review is to summarize available literary data on the role and prognostic value of molecular biological markers p53, UBE2C, CD147, STAT3, VEGF in the carcinogenesis of head and neck squamous cell carcinoma (HNSCC). To date, researches have been studying HNSCC molecular and genetic characteristics and obtaining information about new molecular biological markers that have different functional significance in tumor progression. This review presents current data on protein molecules involved in the HNSCC development, as well as in the formation of drug resistance mechanisms in tumors. The considered markers can be used not only for prognosis but also for developing a new approach to treatment, including patients resistant to therapy or recurrent HNSCC. However, the introduction of these markers into practice requires further examination of their functions and larger-scale studies.
Keywords: HNSCC; Molecular markers; Tumor progression.
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018 Nov) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
-
- Reid PA, Wilson P, Li Y, Marcu LG, Bezak E Current understanding of cancer stem cells: review of their radiobiology and role in head and neck cancers. Head Neck 2017 Sep;39(9):1920–1932. https://doi.org/10.1002/hed.24848 . Epub 2017
-
- Global Burden of Disease Cancer Collaboration (2017) Global, Regional, and National Cancer incidence, mortality, years of Life Lost, Years lived with disability, and disability-adjusted life-years for 32 Cancer Groups, 1990 to 2015: a systematic analysis for the global burden of Disease Study. JAMA Oncol 3(4):524–548. https://doi.org/10.1001/jamaoncol.2016.5688 - DOI - PMC
-
- Machiels JP, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V, EHNS Executive Board (2020 Nov) Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(11):1462–1475. https://doi.org/10.1016/j.annonc.2020.07.011
-
- Marur S, Forastiere AA (2016) Mar;91(3):386 – 96 Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc. https://doi.org/10.1016/j.mayocp.2015.12.017
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
